retatrutide type 2 diabetes trial π¨Breaking: Retatrutide's first Phase 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $5.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 25 - Nov 30


























